Utama › Kanser Paru-paru Bukan Sel Kecil › Ohio › Cleveland
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Cleveland, OH
43 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Cleveland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- dan 2 lagi
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- University Hospitals Cleveland Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 1/2
- Research Site, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #10, Cleveland
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Mengambil pesertaFasa 3
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi jauh
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 3
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center at Chagrin Highlands, Orange · 12 mi jauh
- University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mi jauh
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- University Hospitals Cleveland Medical Center, Cleveland
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- University Hospitals Cleveland Medical Center, Cleveland
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center at Chagrin Highlands, Orange · 12 mi jauh
- University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mi jauh
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi jauh
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Cleveland Clinic, Cleveland
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Mengambil pesertaFasa 2
- Research Site, Cleveland
Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
Mengambil pesertaFasa 2
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Mengambil pesertaFasa 2/3
- The Cleveland Clinic Cancer Center At Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi jauh
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Mengambil pesertaFasa 2/3
- University Hospitals Cleveland Medical Center, Cleveland
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Mengambil pesertaFasa 3
- Clinical Study Site, Cleveland
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Mengambil pesertaFasa 1/2
- Cleveland Clinic, Cleveland
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Mengambil pesertaFasa 2/3
- University Hospitals Cleveland Medical Center, Cleveland
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Mengambil pesertaKajian pemerhatian
- Cleveland Clinic, Cleveland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
Mengambil pesertaFasa 1/2
- Case Western Reserve University, Cleveland
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Mengambil pesertaFasa 1
- Cleveland Clinic, Cleveland
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Mengambil pesertaFasa 1
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Mengambil pesertaFasa 1/2
- Cleveland Clinic Taussig Cancer Center, Cleveland
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Mengambil pesertaFasa 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- Cleveland Clinic, Cleveland
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Cleveland Clinic Taussig Cancer Institute, Cleveland
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- University Hospital - Cleveland Medical Center, Cleveland
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Mengambil pesertaFasa 3
- University Hospitals Cleveland Medical Center, Cleveland
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Mengambil pesertaFasa 1
- University Hospitals Cleveland Medical Center, Cleveland
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Mengambil pesertaFasa 1/2
- University Hospitals Cleveland, Cleveland
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- University Hospitals Cleveland Medical Center, Cleveland
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Research Site, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Mengambil pesertaFasa 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Mengambil pesertaFasa 2
- Cleveland Clinic, Cleveland
A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
Mengambil pesertaFasa 1/2
- Gabrail Cancer Center, Ohio City · 1 mi jauh
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Mengambil peserta
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi jauh
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Mengambil pesertaFasa 1/2
- Cleveland Clinic, Cleveland
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Mengambil pesertaFasa 2
- Cleveland Clinic, Cleveland
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Cleveland
- Kanser (semua jenis)36 kajian
- Kanser Payudara35 kajian
- Kanser Prostat34 kajian
- Kegagalan Jantung33 kajian
- Kanser Ovari30 kajian
- Kanser Metastatik30 kajian
- Kanser Paru-paru26 kajian
- Kanser Kolorektal24 kajian
- Penyakit Kardiovaskular22 kajian
- Kanser Endometrium20 kajian
- Leukemia Mieloid Akut20 kajian
- Penyakit Crohn19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.